Lipomics, UCSD to Study Insulin Resistance; Lipomics to Retain Certain Dx Rights | GenomeWeb
NEW YORK (GenomeWeb News) — Lipomics Technologies and the University of California, San Diego, plan to investigate the underlying mechanisms involved in insulin-resistance disorders.
Under the agreement, Lipomics and UCSD will collaborate on basic and clinical research projects to study non-insulin-dependent diabetes mellitus, obesity, and other insulin-resistance disorders, as well as studies that aim to identify the roles different organ systems play in NIDDM, the company said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.